Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study
Open Access
- 11 October 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 135 (1) , 116-118
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 6 references indexed in Scilit:
- Anticoagulation in coronary interventionEuropean Heart Journal, 2016
- Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial InfarctionJAMA, 2015
- Novel Approaches for Preventing or Limiting Events (Naples) III TrialJACC: Cardiovascular Interventions, 2015
- Bivalirudin Started during Emergency Transport for Primary PCINew England Journal of Medicine, 2013
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Clinical Pharmacology of BivalirudinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002